Compare DFDV & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DFDV | LNSR |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4M | 106.6M |
| IPO Year | 2022 | 2005 |
| Metric | DFDV | LNSR |
|---|---|---|
| Price | $5.44 | $8.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $45.00 | $10.00 |
| AVG Volume (30 Days) | ★ 1.7M | 179.4K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | $2,099,660.00 | ★ $58,435,000.00 |
| Revenue This Year | $32.58 | $10.06 |
| Revenue Next Year | $23.65 | $41.48 |
| P/E Ratio | ★ N/A | $14.10 |
| Revenue Growth | 4.82 | ★ 9.24 |
| 52 Week Low | $2.44 | $4.95 |
| 52 Week High | $18.97 | $12.94 |
| Indicator | DFDV | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 69.94 | 58.35 |
| Support Level | $2.78 | $5.17 |
| Resistance Level | $5.90 | $12.13 |
| Average True Range (ATR) | 0.50 | 0.35 |
| MACD | 0.13 | -0.10 |
| Stochastic Oscillator | 75.80 | 8.65 |
DeFi Development Corp is a U.S. company committed to building its treasury around Solana (SOL), a fast-growing blockchain infrastructure platform. This equity delivers shareholders tangible exposure to SOL price movement and staking rewards, making the firm a proxy for the Solana ecosystem. The treasury extends to running its own validator infrastructure, allowing DFDV to actively participate in and benefit from the Solana network expansion. The firm has two segments: Digital Asset Treasury ("Treasury") and Real Estate Platform ("Real Estate"). The company generates the majority of its revenue from the Treasury segment.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.